Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347
“AGEs are related to the aetiology of diabetes and other metabolic alterations.(34,37,38) They have been shown to be elevated in NASH patients compared to simple steatosis and controls, and to be positively correlated with insulin resistance and negatively with adiponectin.”
BackgroundAdvanced glycation end products in foods and a practical guide to their reduction in the diet
Uribarri, J., Woodruff, S., Goodman, S., Cai, W., Chen, X., Pyzik, R., Yong, A., Striker, G. E., & Vlassara, H. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2010.03.018 · Cited by 1,289
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150
“The combination of increased blood glucose, oxidative and non-oxidative processes result in rearrangements of the Amadori products into the irreversible advanced glycation end products [3,17].”
BackgroundWhy does COVID-19 disproportionately affect older people?
Mueller, A. L., McNamara, M. S., & Sinclair, D. A. (2020) · Aging · doi:10.18632/aging.103344 · Cited by 1,128
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
“Formation of reactive dicarbonyls and AGEs, modified according to [29].”
BackgroundShamloul, R., & Ghanem, H. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60520-0 · Cited by 1,091
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Vincent, A. M., Russell, J. W., Low, P., & Feldman, E. L. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0019 · Cited by 982
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
“AGEs constitute a complex heterogeneous group of compounds that can be produced endogenously or taken up as dietary AGEs [18,27].”
BackgroundProtein carbonylation in human diseases
Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00031-5 · Cited by 961
Diabetic Retinopathy and Diabetic Macular Edema
Ciulla, T. A., Amador, A. G., & Zinman, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2653 · Cited by 836
Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M. (2022) · Cells · doi:10.3390/cells11081312 · Cited by 746
“Among these, so far, the best-characterized are pentosidine and CML [37].”
BackgroundVistoli, G., De Maddis, D., Cipak, A., Zarkovic, N., Carini, M., & Aldini, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.815348 · Cited by 823
Aldehyde Sources, Metabolism, Molecular Toxicity Mechanisms, and Possible Effects on Human Health
O'Brien, P. J., Siraki, A. G., & Shangari, N. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440591002183 · Cited by 738
“…protein glycoxidation or lipoxidation leading to tissue deterioration also occured in several pathological conditions other than diabetes toxicity (Singh et al., 2001b), such as cardiovascular diseases including atherosclerosis (Baynes et al., 2000; Uchida, 2000) and uremia (Miyata et al., 2001),…”
BackgroundDiabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Vascular complications in diabetes mellitus: the role of endothelial dysfunction
Schalkwijk, C. G., & Stehouwer, C. D. A. (2005) · Clinical Science · doi:10.1042/cs20050025 · Cited by 657
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Sparvero, L. J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 622
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic, J., Zengin, A., De Courten, B., Ebeling, P. R., & Scott, D. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s186600 · Cited by 553
“60 AGEs are positivity associated with insulin resistance, obesity, and age.”
BackgroundInsulin resistance as a predictor of age-related diseases
Facchini, F. S., Hua, N., Abbasi, F., & Reaven, G. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7763 · Cited by 594
Ageing, age-related diseases and oxidative stress: What to do next?
Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581
Tomlinson, D. R., & Gardiner, N. J. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2294 · Cited by 564
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
“All of these processes are hypothesized to be pathogenetic mechanisms for these 1146 complications (93,224,227-230).”
BackgroundThe Role of Oxidative Stress in Diabetic Complications
Niedowicz, D. M., & Daleke, D. L. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:2:289 · Cited by 524
“The Schiff base is then reduced to an Amadori product and subsequent oxidations and crosslinking occur, yielding a diverse group of modifications referred to as AGE (275,276).”
BackgroundInfluentialHow does diabetes accelerate Alzheimer disease pathology?
Sims-Robinson, C., Kim, B., Rosko, A., & Feldman, E. L. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.130 · Cited by 492
The Naked Mole-Rat: A New Long-Living Model for Human Aging Research
Buffenstein, R. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1369 · Cited by 461
“High levels of advanced glycation end products occur when glucose handling is impaired, as is commonly reported in age-related chronic diseases such as diabetes ( 52 ).”
BackgroundAbnormal angiogenesis in diabetes mellitus
Martin, A., Komada, M. R., & Sane, D. C. (2003) · Medicinal Research Reviews · doi:10.1002/med.10024 · Cited by 455
Glucose and reactive oxygen species
Bonnefont-Rousselot, D. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200209000-00016 · Cited by 456
Ageing and diabetes: implications for brain function
Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. A. W., & Gispen, W. H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01486-3 · Cited by 458
Hyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
“It may be noted that glucose is less efficient than the other reducing monosaccharides (307).”
Insulin and Insulin Resistance in Alzheimer’s Disease
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189987 · Cited by 377
Review: Glycation of human serum albumin
Anguizola, J., Matsuda, R., Barnaby, O. S., Hoy, K. S., Wa, C., DeBolt, E., Koke, M., & Hage, D. S. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.013 · Cited by 395
“The next stage of the glycation process involves the oxidation of adducts on glycated proteins or free sugars to form intermediate reactive dicarbonyl compounds, or α-oxaloaldehydes [28, 88, 112– 118].”
Limonene: Aroma of innovation in health and disease
Vieira, A. J., Beserra, F. P., Souza, M. C., Totti, B. M., & Rozza, A. L. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.02.007 · Cited by 384
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J. L., Naves-Díaz, M., Carrillo-López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 372
“Another source of AGEs is the food, a recently metaanalysis showed that a diet with high AGE content would be linked to the development of cardio-metabolic risk factors, while a low AGE intake might be beneficial in patients with metabolic disorders such as diabetes, as it reduces the insulin resistance and the choles…”
BackgroundInfluentialChronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
“Glycated lipoproteins, including very low-density lipoprotein cholesterol (VLDL-C), LDL-C, and also HDL-C, are believed to contribute to atherosclerotic CVD by impairing lipoprotein metabolism [156] Glycated lipoproteins are catabolized more slowly.”
BackgroundAdvanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 387
“To fuel this process, glucose is an ubiquitous and predominant substrate, but other sugar molecules such as fructose, threose, glucose 6-phosphate, and glyceraldehyde 3 phosphate may also react similarly with proteins and produce chemically distinct AGEs according to the reaction partners, respectively (87, 128).”
BackgroundAlikhani, M., Alikhani, Z., Boyd, C., MacLellan, C. M., Raptis, M., Liu, R., Pischon, N., Trackman, P. C., Gerstenfeld, L., & Graves, D. T. (2007) · Bone · doi:10.1016/j.bone.2006.09.011 · Cited by 376
“AGEs have been shown to be etiologic factors in diabetes-induced nephropathy, retinopathy, neuropathy, and diabetes-accelerated atherosclerosis (40,44,50).”
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
Establishment of the mimetic aging effect in mice caused by D-galactose
Ho, S.-C., Liu, J.-H., & Wu, R.-Y. (2003) · Biogerontology · doi:10.1023/a:1022417102206 · Cited by 359
“This process, also known as the Maillard reaction, was noted (Brownlee 1995; Chellan et al. 2001; Singh et al. 2001).”
BackgroundCommon pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
“The binding of AGE to RAGE induces the diabetic vascular complications (Singh et al., 2001).”
Background1,2-Dicarbonyl Compounds in Commonly Consumed Foods
Degen, J., Hellwig, M., & Henle, T. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf301306g · Cited by 359
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.-B., Park, Y. M., Salekdeh, G. H., & Lee, B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.030 · Cited by 357
“AGEs are a heterogeneous group of irreversible products resulting from nonenzymatic glycation and oxidation of proteins, nucleic acids, and lipids (Goldin et al., 2006; Singh et al., 2001).”
Polyphenols with antiglycation activity and mechanisms of action: A review of recent findings
Yeh, W.-J., Hsia, S.-M., Lee, W.-H., & Wu, C.-H. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2016.10.017 · Cited by 353
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
HAYAT, S. A., PATEL, B., KHATTAR, R. S., & MALIK, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 352
The Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
Kay, A. M., Simpson, C. L., & Stewart, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6809703 · Cited by 346
“It is reported that the death rate from cardiovascular disease for an individual, 18 years and older, with diabetes was about 1.7 times higher than the normal population [1].”
BackgroundInfluentialHealth benefits of resveratrol administration
Galiniak, S., Aebisher, D., & Bartusik-Aebisher, D. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2749 · Cited by 333
The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
ABA and sugar interactions regulating development: cross-talk or voices in a crowd?
Finkelstein, R. R., & Gibson, S. I. (2002) · Current Opinion in Plant Biology · doi:10.1016/s1369-5266(01)00225-4 · Cited by 337
Nephrin Expression Is Reduced in Human Diabetic Nephropathy
Doublier, S., Salvidio, G., Lupia, E., Ruotsalainen, V., Verzola, D., Deferrari, G., & Camussi, G. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1023 · Cited by 344
“It was shown recently that RAGE is expressed in kidney on normal podocytes and upregulated in DN (45).”
InfluentialDiabetes and Advanced Glycoxidation End Products
Huebschmann, A. G., Regensteiner, J. G., Vlassara, H., & Reusch, J. E. B. (2006) · Diabetes Care · doi:10.2337/dc05-2096 · Cited by 330
Fishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
Tan, K. C. B., Chow, W.-S., Ai, V. H. G., Metz, C., Bucala, R., & Lam, K. S. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1055 · Cited by 319
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“236 Advanced glycation end products (AGEs) formation: Chronic hyperglycemia promotes the non-enzymatic glycation of proteins, lipids, and nucleic acids, leading to the formation of AGEs.”
Protein kinase C and the development of diabetic vascular complications
Way, K. J., Katai, N., & King, G. L. (2001) · Diabetic Medicine · doi:10.1046/j.0742-3071.2001.00638.x · Cited by 313
Irie, F., Fitzpatrick, A. L., Lopez, O. L., Kuller, L. H., Peila, R., Newman, A. B., & Launer, L. J. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.29 · Cited by 305
Hofmann, S. M., Dong, H.-J., Li, Z., Cai, W., Altomonte, J., Thung, S. N., Zeng, F., Fisher, E. A., & Vlassara, H. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2082 · Cited by 296
“MG, which has been linked to cellular oxidant stress and apoptosis (17), and CML, which is formed by glycoxidation as well as by lipoxidation (18), have both been identified in vivo and are linked to tissue toxicity (10,16,19).”
BackgroundInfluentialZelber-Sagi, S., Ivancovsky-Wajcman, D., Fliss Isakov, N., Webb, M., Orenstein, D., Shibolet, O., & Kariv, R. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.015 · Cited by 297
Cardiomyopathy in obesity, insulin resistance and diabetes
Nakamura, M., & Sadoshima, J. (2020) · The Journal of Physiology · doi:10.1113/jp276747 · Cited by 286
“These toxic metabolites contribute to the generation of advanced glycation end products (AGEs) (Singh et al. 2001), which modify proteins and nucleic acids, thereby impairing their functions.”
BackgroundEvaluating All Potential Oral Complications of Diabetes Mellitus
Verhulst, M. J. L., Loos, B. G., Gerdes, V. E. A., & Teeuw, W. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00056 · Cited by 276
Dangers Within: DAMP Responses to Damage and Cell Death in Kidney Disease
Rosin, D. L., & Okusa, M. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040430 · Cited by 284
Pirola, L., Johnston, A. M., & Van Obberghen, E. (2004) · Diabetologia · doi:10.1007/s00125-003-1313-3 · Cited by 283
“These glycated proteins are further degraded to AGE, a heterogeneous class of compounds which includes glyoxal, methylglyoxal, carboxymethyl-lysine and others [128].”
BackgroundInsulin Resistance and Alzheimer’s Disease: Bioenergetic Linkages
Neth, B. J., & Craft, S. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00345 · Cited by 272
“A powerful mediator of inflammation and vascular dysfunction common to both insulin resistance and AD are advanced glycation end products (AGEs), which are glycated proteins and lipids formed through non-enzymatic glycosylation after exposure to glucose (Singh et al., 2001).”
BackgroundGomes, M. B., & Negrato, C. A. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-80 · Cited by 269
“Another important factor in the pathogenesis of diabetesrelated complications is the formation of advanced glycation end-products (AGEs) which are derived from intracellular glucose auto-oxidation and non-enzymatic reactions between glucose and intracellular and extracellular proteins [130-133].”
BackgroundThe Role of Advanced Glycation End Products in Diabetic Vascular Complications
Rhee, S. Y., & Kim, Y. S. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0105 · Cited by 274
Nε-(carboxymethyl)lysine content of foods commonly consumed in a Western style diet
Hull, G. L. J., Woodside, J. V., Ames, J. M., & Cuskelly, G. J. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.08.055 · Cited by 263
Safi, S. Z., Qvist, R., Kumar, S., Batumalaie, K., & Ismail, I. S. B. (2014) · BioMed Research International · doi:10.1155/2014/801269 · Cited by 257
“…should be addressed to Sher Zaman Safi; safi.nust@yahoo.com Received 14 February 2014; Revised 4 May 2014; Accepted 24 May 2014; Published 6 July 2014 Academic Editor: Denise McDonald Copyright © 2014 Sher Zaman Safi et al.This is an open access article distributed under…”
BackgroundDiabetes-induced erectile dysfunction: epidemiology, pathophysiology and management
Thorve, V. S., Kshirsagar, A. D., Vyawahare, N. S., Joshi, V. S., Ingale, K. G., & Mohite, R. J. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2010.03.003 · Cited by 269
Bivalacqua, T. J., Usta, M. F., Champion, H. C., Kadowitz, P. J., & Hellstrom, W. J. G. (2003) · Journal of Andrology · doi:10.1002/j.1939-4640.2003.tb02743.x · Cited by 268
“Through a series of oxidative and nonoxidative reactions, advanced glycation end products (AGEs) are formed irreversibly and accumulate in tissues over time, in particular endothelial and vascular smooth muscle cells (Singh et al, 2001).”
BackgroundPeng, X., Cheng, K.-W., Ma, J., Chen, B., Ho, C.-T., Lo, C., Chen, F., & Wang, M. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf073065v · Cited by 263
Vincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., & Feldman, E. L. (2007) · Endocrinology · doi:10.1210/en.2006-0073 · Cited by 258
“Diet modification to decrease AGE intake and/or increase antioxidant levels through plant-derived flavonoid intake may prove efficacious (12).”
BackgroundInfluentialOxidative Stress Signaling to Chromatin in Health and Disease
Kreuz, S., & Fischle, W. (2016) · Epigenomics · doi:10.2217/epi-2016-0002 · Cited by 250
Yamamoto, M., Yamaguchi, T., Yamauchi, M., Yano, S., & Sugimoto, T. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1270 · Cited by 264
Montonen, J., Järvinen, R., Knekt, P., Heliövaara, M., & Reunanen, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1447 · Cited by 265
Diabetes and Alzheimer’s disease crosstalk
Baglietto-Vargas, D., Shi, J., Yaeger, D. M., Ager, R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 256
The role of collagen crosslinks in ageing and diabetes - the good, the bad, and the ugly
Snedeker, J. G. (2014) · Muscles, Ligaments and Tendons Journal · doi:10.11138/mltj/2014.4.3.303 · Cited by 180
Protein oxidation in aging and the removal of oxidized proteins
Höhn, A., König, J., & Grune, T. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.01.004 · Cited by 238
“[148] Singh R, Barden A, Mori T, Beilin L.”
BackgroundUremic Toxicity of Advanced Glycation End Products in CKD
Stinghen, A. E. M., Massy, Z. A., Vlassara, H., Striker, G. E., & Boullier, A. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101047 · Cited by 242
Naturally occurring inhibitors against the formation of advanced glycation end-products
Peng, X., Ma, J., Chen, F., & Wang, M. (2011) · Food & Function · doi:10.1039/c1fo10034c · Cited by 244
Protein carbonylation and metal-catalyzed protein oxidation in a cellular perspective
Møller, I. M., Rogowska-Wrzesinska, A., & Rao, R. S. P. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.004 · Cited by 233
Melanoidins Formed by Maillard Reaction in Food and Their Biological Activity
Echavarría, A. P., Pagán, J., & Ibarz, A. (2012) · Food Engineering Reviews · doi:10.1007/s12393-012-9057-9 · Cited by 224
“For this reason studies on MRPs absorption and metabolism with realistic designs and concentrations of the compounds are a necessary step to establish the effects of their consumption, and its relation with the endogenously formed Maillard compounds, also called advanced glycation end-products (AGEs) [161].”
BackgroundImportance of measuring products of non-enzymatic glycation of proteins
Lapolla, A., Traldi, P., & Fedele, D. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.09.007 · Cited by 236
The medicinal properties and phytochemistry of plants of the genus Terminalia (Combretaceae)
Cock, I. E. (2015) · Inflammopharmacology · doi:10.1007/s10787-015-0246-z · Cited by 218
A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Wojcik, M., Burzynska-Pedziwiatr, I., & Wozniak, L. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792231950 · Cited by 234
Pericytes, an overlooked player in vascular pathobiology
Ferland-McCollough, D., Slater, S., Richard, J., Reni, C., & Mangialardi, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.008 · Cited by 230
Chilelli, N. C., Burlina, S., & Lapolla, A. (2013) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.04.004 · Cited by 226
High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
Yuan, S., Liu, Z., Xu, Z., Liu, J., & Zhang, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00920-3 · Cited by 226
Insulin Signal Transduction Perturbations in Insulin Resistance
Khalid, M., Alkaabi, J., Khan, M. A. B., & Adem, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168590 · Cited by 233
“As a consequence, the production of inflammatory cytokines, chemokines, oxidative stress, and activation of signaling cascades related to cellular toxicity results in beta cell damage and degradation [37,51,102].”
BackgroundSalivary markers of oxidative stress in oral diseases
Tóthová, L., Kamodyová, N., Červenka, T., & Celec, P. (2015) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2015.00073 · Cited by 217
“In addition to endogenously formed, AGEs can also be derived from exogenous sources such as smoking and food (Singh et al., 2001; Nass et al., 2007).”
BackgroundHyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells
Kränkel, N., Adams, V., Linke, A., Gielen, S., Erbs, S., Lenk, K., Schuler, G., & Hambrecht, R. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000156401.04325.8f · Cited by 230
Snelson, M., & Coughlan, M. (2019) · Nutrients · doi:10.3390/nu11020215 · Cited by 230
“Crosslinking of extracellular matrix proteins by AGEs contributes to thickening of the basement membrane and glomerulosclerosis within the kidney as well as arterial stiffness, which contributes to atherosclerosis [36].”
BackgroundGuimarães, E. L. M., Empsen, C., Geerts, A., & van Grunsven, L. A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.007 · Cited by 226
“Discussion AGEs are formed at high rates during metabolic syndrome and have been demonstrated to induce ROS formation [2,19].”
BackgroundAdvanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226
Therapeutic potential of breakers of advanced glycation end product–protein crosslinks
Vasan, S., Foiles, P., & Founds, H. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.016 · Cited by 221
Amyloid peptides and proteins in review
Harrison, R. S., Sharpe, P. C., Singh, Y., & Fairlie, D. P. (2007) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_2007_0701 · Cited by 212
Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
Cepas, V., Collino, M., Mayo, J. C., & Sainz, R. M. (2020) · Antioxidants · doi:10.3390/antiox9020142 · Cited by 202
Alikhani, Z., Alikhani, M., Boyd, C. M., Nagao, K., Trackman, P. C., & Graves, D. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406313200 · Cited by 212
Chapter 3 Carnosine and Its Possible Roles in Nutrition and Health
Hipkiss, A. R. (2009) · Advances in Food and Nutrition Research · doi:10.1016/s1043-4526(09)57003-9 · Cited by 211
“…where glucose, or more likely its metabolites and by-products, chemically modify intracellular and extracellular proteins and aminolipids via the process called glycation (Ahmed and Thornalley, 2007; Goh and Cooper, 2008; Magalhaes et al., 2008; Singh et al., 2001; Vlassara and Palace, 2002).”
Background
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.